$SNBR
Sleep Number Corp

2022 Q1 Form 10-K Financial Statement

#000082718722000012 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2022 2021 Q1
Revenue $492.0M $2.185B $567.9M
YoY Change -13.37% 17.69% 20.17%
Cost Of Revenue $212.3M $866.1M $212.0M
YoY Change 0.12% 23.63% 24.39%
Gross Profit $279.7M $1.319B $355.9M
YoY Change -21.4% 14.09% 17.8%
Gross Profit Margin 56.86% 60.36% 62.67%
Selling, General & Admin $250.2M $1.067B $268.8M
YoY Change -6.93% 14.68% 12.56%
% of Gross Profit 89.43% 80.89% 75.53%
Research & Development $14.91M $58.54M $12.50M
YoY Change 19.26% 43.09% 19.04%
% of Gross Profit 5.33% 4.44% 3.51%
Depreciation & Amortization $15.61M $60.39M $15.40M
YoY Change 1.35% -1.9% 0.19%
% of Gross Profit 5.58% 4.58% 4.33%
Operating Expenses $265.1M $1.125B $281.3M
YoY Change -5.77% 15.88% 12.83%
Operating Profit $14.66M $193.5M $74.60M
YoY Change -80.35% 4.67% 41.25%
Interest Expense -$1.845M -$6.245M -$800.0K
YoY Change 130.63% -29.83% -65.22%
% of Operating Profit -12.59% -3.23% -1.07%
Other Income/Expense, Net
YoY Change
Pretax Income $12.81M $187.3M $73.80M
YoY Change -82.64% 6.43% 46.23%
Income Tax $1.671M $33.55M $12.40M
% Of Pretax Income 13.04% 17.91% 16.8%
Net Earnings $11.14M $153.7M $61.40M
YoY Change -81.86% 10.46% 56.87%
Net Earnings / Revenue 2.26% 7.04% 10.81%
Basic Earnings Per Share $6.40
Diluted Earnings Per Share $467.8K $6.16 $2.193M
COMMON SHARES
Basic Shares Outstanding 22.69M shares 24.04M shares 25.38M shares
Diluted Shares Outstanding 24.95M shares

Balance Sheet

Concept 2022 Q1 2022 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.389M $2.389M $4.200M
YoY Change -43.12% -43.12% -98.24%
Cash & Equivalents $2.389M $2.389M $4.243M
Short-Term Investments
Other Short-Term Assets $54.92M $45.82M $43.49M
YoY Change 26.28% 21.54% 40.79%
Inventory $105.6M $105.6M $81.36M
Prepaid Expenses $18.95M $20.84M
Receivables $25.72M $53.77M $31.87M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $207.6M $207.6M $181.8M
YoY Change 14.2% 14.2% -51.23%
LONG-TERM ASSETS
Property, Plant & Equipment $195.1M $566.3M $175.2M
YoY Change 11.36% 15.71% -10.01%
Goodwill $64.00M $64.00M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $75.19M $25.85M $56.01M
YoY Change 34.24% 43.59% 12.31%
Total Long-Term Assets $711.9M $711.9M $618.3M
YoY Change 15.14% 15.14% -3.54%
TOTAL ASSETS
Total Short-Term Assets $207.6M $207.6M $181.8M
Total Long-Term Assets $711.9M $711.9M $618.3M
Total Assets $919.5M $919.5M $800.1M
YoY Change 14.92% 14.93% -21.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $162.5M $162.5M $91.90M
YoY Change 76.87% 76.87% -30.87%
Accrued Expenses $168.1M $168.1M $163.6M
YoY Change 2.72% 2.72% 49.0%
Deferred Revenue
YoY Change
Short-Term Debt $382.5M $382.5M $244.2M
YoY Change 56.63% 56.63% -45.25%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $906.8M $906.8M $655.9M
YoY Change 38.24% 38.25% -17.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.8M $437.0M $84.84M
YoY Change 18.85% 18.79% 19.57%
Total Long-Term Liabilities $100.8M $437.0M $84.84M
YoY Change 18.85% 18.79% 19.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $906.8M $906.8M $655.9M
Total Long-Term Liabilities $100.8M $437.0M $84.84M
Total Liabilities $1.344B $1.344B $1.024B
YoY Change 31.28% 31.29% -12.45%
SHAREHOLDERS EQUITY
Retained Earnings -$429.2M -$224.2M
YoY Change 91.39% 43.57%
Common Stock $4.198M $254.0K
YoY Change 1552.76% -7.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$425.0M -$425.0M -$224.0M
YoY Change
Total Liabilities & Shareholders Equity $919.5M $919.5M $800.1M
YoY Change 14.92% 14.93% -21.08%

Cashflow Statement

Concept 2022 Q1 2022 2021 Q1
OPERATING ACTIVITIES
Net Income $11.14M $153.7M $61.40M
YoY Change -81.86% 10.46% 56.87%
Depreciation, Depletion And Amortization $15.61M $60.39M $15.40M
YoY Change 1.35% -1.9% 0.19%
Cash From Operating Activities $7.326M $300.0M -$7.600M
YoY Change -196.39% 7.28% -108.95%
INVESTING ACTIVITIES
Capital Expenditures -$17.53M $66.90M -$10.10M
YoY Change 73.56% 80.32% -197.58%
Acquisitions
YoY Change
Other Investing Activities $0.00 $257.0K $0.00
YoY Change 157.0%
Cash From Investing Activities -$17.53M -$66.64M -$10.00M
YoY Change 75.3% 70.8% -3.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $377.9M
YoY Change 67.2%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.76M -$235.2M 20.50M
YoY Change -47.5% -1.16% -87.42%
NET CHANGE
Cash From Operating Activities 7.326M $300.0M -7.600M
Cash From Investing Activities -17.53M -$66.64M -10.00M
Cash From Financing Activities 10.76M -$235.2M 20.50M
Net Change In Cash 559.0K -$1.854M 2.900M
YoY Change -80.72% -169.96% -98.78%
FREE CASH FLOW
Cash From Operating Activities $7.326M $300.0M -$7.600M
Capital Expenditures -$17.53M $66.90M -$10.10M
Free Cash Flow $24.86M $233.1M $2.500M
YoY Change 894.24% -3.9% -96.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000827187
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-01-01
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-25121
CY2022 dei Entity Registrant Name
EntityRegistrantName
SLEEP NUMBER CORPORATION
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1597886
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-424953000 USD
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1001 Third Avenue South
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55404
CY2022 dei City Area Code
CityAreaCode
763
CY2022 dei Local Phone Number
LocalPhoneNumber
551-7000
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022 dei Trading Symbol
TradingSymbol
SNBR
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100508000 USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33545000 USD
CY2021Q3 dei Entity Public Float
EntityPublicFloat
1734376000 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22685000 shares
CY2022 dei Auditor Name
AuditorName
DELOITTE & TOUCHE LLP
CY2022 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2389000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4243000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
924000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1046000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25718000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31871000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
105644000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
81362000 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18953000 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20839000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
54917000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
43489000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
207621000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
181804000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
195128000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175223000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
371133000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
314226000 USD
CY2022Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
70468000 USD
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
72871000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75190000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56012000 USD
CY2022Q1 us-gaap Assets
Assets
919540000 USD
CY2021Q1 us-gaap Assets
Assets
800136000 USD
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
382500000 USD
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
244200000 USD
CY2022Q1 snbr Customer Prepayments Current
CustomerPrepaymentsCurrent
129499000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
162547000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
91904000 USD
CY2021Q1 snbr Customer Prepayments Current
CustomerPrepaymentsCurrent
72017000 USD
CY2022Q1 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
22368000 USD
CY2021Q1 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
24765000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51240000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
76786000 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
22087000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
23339000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72360000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
62077000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
64177000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60856000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
906778000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
655944000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
688000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
242000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
336192000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
283084000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
100835000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
84844000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1344493000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1024114000 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
142500000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
142500000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22683000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22683000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25390000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25390000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
227000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
254000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3971000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-429151000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-224232000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-223978000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
919540000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
800136000 USD
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2184949000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1856555000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1698352000 USD
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
866102000 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
700555000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
646429000 USD
CY2022 us-gaap Gross Profit
GrossProfit
1318847000 USD
CY2021 us-gaap Gross Profit
GrossProfit
1156000000 USD
CY2019 us-gaap Gross Profit
GrossProfit
1051923000 USD
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
905359000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
771195000 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
766922000 USD
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
161412000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40910000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34950000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158999000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
137956000 USD
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58540000 USD
CY2022 us-gaap Operating Expenses
OperatingExpenses
1125311000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
971104000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
939828000 USD
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
193536000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
184896000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
112095000 USD
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6245000 USD
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8924000 USD
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11587000 USD
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
187291000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
175972000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36783000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18663000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
153746000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139189000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
81845000 USD
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.40
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.03
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.78
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24038000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27665000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29472000 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.16
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.90
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24947000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28428000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30355000 shares
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-109550000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
81845000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7190000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16657000 USD
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
155573000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-159431000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139189000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9602000 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21813000 USD
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
235151000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-223978000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
153746000 USD
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4441000 USD
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23214000 USD
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
382376000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-424953000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
153746000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139189000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
81845000 USD
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
60394000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
61563000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
61866000 USD
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
23214000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
21813000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
16657000 USD
CY2022 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-37000 USD
CY2021 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-247000 USD
CY2019 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
430000 USD
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
446000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3566000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1014000 USD
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6153000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11893000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4817000 USD
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24282000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5703000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2183000 USD
CY2022 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-3066000 USD
CY2021 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
1057000 USD
CY2019 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
3066000 USD
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13836000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13717000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13959000 USD
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
54405000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16755000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10661000 USD
CY2022 snbr Increase Decrease In Prepayments From Customer
IncreaseDecreaseInPrepaymentsFromCustomer
57482000 USD
CY2021 snbr Increase Decrease In Prepayments From Customer
IncreaseDecreaseInPrepaymentsFromCustomer
37769000 USD
CY2019 snbr Increase Decrease In Prepayments From Customer
IncreaseDecreaseInPrepaymentsFromCustomer
7182000 USD
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-24790000 USD
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
36825000 USD
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12920000 USD
CY2022 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
1814000 USD
CY2021 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
111000 USD
CY2019 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
725000 USD
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8293000 USD
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
21315000 USD
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7007000 USD
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
300010000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
279661000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
189160000 USD
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66900000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37100000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59239000 USD
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
257000 USD
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000 USD
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2615000 USD
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1973000 USD
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66643000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39018000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56624000 USD
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
382376000 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
235644000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
165079000 USD
CY2022 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
145473000 USD
CY2021 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-11639000 USD
CY2019 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
26357000 USD
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2759000 USD
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4441000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9602000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7190000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
312000 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1023000 USD
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-235221000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-237993000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-132555000 USD
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1854000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2650000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4243000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1593000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1612000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2389000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4243000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1593000 USD
CY2022 snbr Change In Unsettled Repurchases Of Common Stock
ChangeInUnsettledRepurchasesOfCommonStock
0 USD
CY2021 snbr Change In Unsettled Repurchases Of Common Stock
ChangeInUnsettledRepurchasesOfCommonStock
-493000 USD
CY2019 snbr Change In Unsettled Repurchases Of Common Stock
ChangeInUnsettledRepurchasesOfCommonStock
-9506000 USD
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36305000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38698000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17182000 USD
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5438000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
9053000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
10656000 USD
CY2022 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
13968000 USD
CY2021 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
5015000 USD
CY2019 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
5725000 USD
CY2022 us-gaap Fiscal Period
FiscalPeriod
<div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to December 31. Fiscal years and their respective fiscal year ends were as follows: fiscal 2021 ended January 1, 2022; fiscal 2020 ended January 2, 2021; and fiscal 2019 ended December 28, 2019. Fiscal 2020 had 53 weeks, 2021 and 2019 each had 52 weeks.</span></div>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the financial statements in future periods. Additionally, based on the duration and severity of the current global situation involving the novel coronavirus (COVID-19) pandemic, including but not limited to general economic conditions, inflation, consumer confidence, store restrictions mandated by federal, state and/or local authorities and global supply-chain disruptions, the extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Avenir LT Pro 45 Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical accounting policies consist of stock-based compensation, warranty liabilities and revenue recognition.</span></div>
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12152000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11345000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10389000 USD
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
16732000 USD
CY2021 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
13387000 USD
CY2019 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
10949000 USD
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
18134000 USD
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
12158000 USD
CY2019 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
11007000 USD
CY2022 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-681000 USD
CY2021 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-422000 USD
CY2019 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
1014000 USD
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10069000 USD
CY2021Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12152000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11345000 USD
CY2022 snbr Leverage Ratio
LeverageRatio
3.75
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
403000000 USD
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000 USD
CY2022 us-gaap Advertising Expense
AdvertisingExpense
323000000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
253000000 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
242000000 USD
CY2022Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
13000000 USD
CY2021Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
11000000 USD
CY2022Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
9000000 USD
CY2021Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
7000000 USD
CY2022Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
4000000 USD
CY2021Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
4000000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2500000 shares
CY2022Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
11752000 USD
CY2021Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
12599000 USD
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
83000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
103000 USD
CY2022Q1 snbr Inventory Finished Goods And Components Net
InventoryFinishedGoodsAndComponentsNet
93809000 USD
CY2021Q1 snbr Inventory Finished Goods And Components Net
InventoryFinishedGoodsAndComponentsNet
68660000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
105644000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
81362000 USD
CY2022Q1 snbr Finished Beds Included In Finished Goods Inventory Net
FinishedBedsIncludedInFinishedGoodsInventoryNet
40686000 USD
CY2021Q1 snbr Finished Beds Included In Finished Goods Inventory Net
FinishedBedsIncludedInFinishedGoodsInventoryNet
21442000 USD
CY2022Q1 snbr Finished Components Included In Finished Goods Inventory Net
FinishedComponentsIncludedInFinishedGoodsInventoryNet
32835000 USD
CY2021Q1 snbr Finished Components Included In Finished Goods Inventory Net
FinishedComponentsIncludedInFinishedGoodsInventoryNet
28108000 USD
CY2022Q1 snbr Retail Accessories Included In Finished Goods Inventory Net
RetailAccessoriesIncludedInFinishedGoodsInventoryNet
20288000 USD
CY2021Q1 snbr Retail Accessories Included In Finished Goods Inventory Net
RetailAccessoriesIncludedInFinishedGoodsInventoryNet
19110000 USD
CY2022Q1 snbr Inventory Finished Goods And Components Net
InventoryFinishedGoodsAndComponentsNet
93809000 USD
CY2021Q1 snbr Inventory Finished Goods And Components Net
InventoryFinishedGoodsAndComponentsNet
68660000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
344024000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
306278000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
195128000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175223000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
64000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
64000000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2403000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1431000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
222000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
226000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
222000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
522000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5026000 USD
CY2022Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
825000000 USD
CY2022Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
825000000 USD
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1200000000 USD
CY2022Q1 snbr Maximum Leverage Ratio
MaximumLeverageRatio
4.5
CY2022Q1 snbr Minimum Interest Coverage Ratio
MinimumInterestCoverageRatio
3.0
CY2022Q1 us-gaap Debt Current
DebtCurrent
382500000 USD
CY2021Q1 us-gaap Debt Current
DebtCurrent
244200000 USD
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3997000 USD
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3997000 USD
CY2022Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
438503000 USD
CY2021Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
201803000 USD
CY2022Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.016
CY2021Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.015
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
99474000 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
90311000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
86026000 USD
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
2205000 USD
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
1147000 USD
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
1809000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
94881000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
85944000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
74288000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
64404000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
53113000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
118977000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
491607000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
83055000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
408552000 USD
CY2022Q1 snbr Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
82000000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72000000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
90198000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
85497000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
81718000 USD
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
109000000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
43860000 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
75384000 USD
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23214000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21813000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16657000 USD
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5722000 USD
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5126000 USD
CY2019 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3998000 USD
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
17492000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
16687000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
12659000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
813000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.74
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41568000 USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
63000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
143.06
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
175000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
25.42
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
69.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
699000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.02
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28258000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
496000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.24
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
22993000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
685000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
41.58
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
27937000 USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
71.93
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.10
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.97
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
16003000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14357000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9636000 USD
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4400000 USD
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
3900000 USD
CY2022 snbr Stock Repurchased Acquired Through Share Repurchase Program Total
StockRepurchasedAcquiredThroughShareRepurchaseProgramTotal
364479000 USD
CY2021 snbr Stock Repurchased Acquired Through Share Repurchase Program Total
StockRepurchasedAcquiredThroughShareRepurchaseProgramTotal
228111000 USD
CY2019 snbr Stock Repurchased Acquired Through Share Repurchase Program Total
StockRepurchasedAcquiredThroughShareRepurchaseProgramTotal
145900000 USD
CY2022 snbr Stock Repurchase Acquired Through Tax Withholding Restricted Stock
StockRepurchaseAcquiredThroughTaxWithholdingRestrictedStock
17897000 USD
CY2021 snbr Stock Repurchase Acquired Through Tax Withholding Restricted Stock
StockRepurchaseAcquiredThroughTaxWithholdingRestrictedStock
7040000 USD
CY2019 snbr Stock Repurchase Acquired Through Tax Withholding Restricted Stock
StockRepurchaseAcquiredThroughTaxWithholdingRestrictedStock
9673000 USD
CY2022 snbr Stock Repurchase During Period Value Disclosure
StockRepurchaseDuringPeriodValueDisclosure
382376000 USD
CY2021 snbr Stock Repurchase During Period Value Disclosure
StockRepurchaseDuringPeriodValueDisclosure
235151000 USD
CY2019 snbr Stock Repurchase During Period Value Disclosure
StockRepurchaseDuringPeriodValueDisclosure
155573000 USD
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000 USD
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
403000000 USD
CY2022 us-gaap Net Income Loss
NetIncomeLoss
153746000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
139189000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
81845000 USD
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24038000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27665000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29472000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
909000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
763000 shares
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
883000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24947000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28428000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30355000 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.40
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.03
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.78
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.16
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.90
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
CY2022Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
77391000 USD
CY2021Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
64569000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
100170000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
84977000 USD
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
29000000 USD
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
34000000 USD
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
32000000 USD
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2184949000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1856555000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1698352000 USD
CY2021Q1 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
24765000 USD
CY2019Q4 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
19809000 USD
CY2022 snbr Contract With Customer Refund Liability Additions
ContractWithCustomerRefundLiabilityAdditions
91975000 USD
CY2021 snbr Contract With Customer Refund Liability Additions
ContractWithCustomerRefundLiabilityAdditions
81513000 USD
CY2022 snbr Contract With Customer Refund Liability Deductions
ContractWithCustomerRefundLiabilityDeductions
94372000 USD
CY2021 snbr Contract With Customer Refund Liability Deductions
ContractWithCustomerRefundLiabilityDeductions
76557000 USD
CY2022Q1 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
22368000 USD
CY2021Q1 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
24765000 USD
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.50
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
7000000 USD
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6000000 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6000000 USD
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
17019000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
29762000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
12299000 USD
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4568000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6528000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3293000 USD
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
21587000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
36290000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
15592000 USD
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
10954000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
584000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2591000 USD
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1004000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-91000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
480000 USD
CY2022 snbr Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
11958000 USD
CY2021 snbr Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
493000 USD
CY2019 snbr Deferred Income Tax Expense Benefit Net
DeferredIncomeTaxExpenseBenefitNet
3071000 USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33545000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36783000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18663000 USD
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.030
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.024
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.036
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.063
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.024
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.043
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.014
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.022
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.015
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.010
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.005
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.179
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.186
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8037000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7518000 USD
CY2022Q1 snbr Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
102292000 USD
CY2021Q1 snbr Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
86692000 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
7459000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
8496000 USD
CY2022Q1 snbr Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards And Deferred Tax Credits
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwardsAndDeferredTaxCredits
1939000 USD
CY2021Q1 snbr Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards And Deferred Tax Credits
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwardsAndDeferredTaxCredits
2027000 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
8206000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
6045000 USD
CY2022Q1 snbr Deferred Tax Assets Tax Deferred Expense Other Long Term
DeferredTaxAssetsTaxDeferredExpenseOtherLongTerm
6607000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
31881000 USD
CY2021Q1 snbr Deferred Tax Assets Tax Deferred Expense Other Long Term
DeferredTaxAssetsTaxDeferredExpenseOtherLongTerm
7440000 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
134540000 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
118218000 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
615000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
615000 USD
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
133925000 USD
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
117603000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
34655000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
92778000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
78824000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
5460000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
4987000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1720000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2153000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
134613000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
117845000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
688000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
242000 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
600000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3912000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3337000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3866000 USD
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
831000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
860000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
638000 USD
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
4000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
27000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
134000 USD
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
33000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
275000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
363000 USD
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
845000 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
312000 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
663000 USD
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3869000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3912000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3337000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3700000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3600000 USD
CY2022Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
56000000 USD
CY2022 dei Auditor Firm
AuditorFirmId
34

Files In Submission

Name View Source Status
0000827187-22-000012-index-headers.html Edgar Link pending
0000827187-22-000012-index.html Edgar Link pending
0000827187-22-000012.txt Edgar Link pending
0000827187-22-000012-xbrl.zip Edgar Link pending
a2021-q4ex1035.htm Edgar Link pending
a2021-q4ex1036.htm Edgar Link pending
a2021-q4ex1048.htm Edgar Link pending
a2021-q4ex211.htm Edgar Link pending
a2021-q4ex231.htm Edgar Link pending
a2021-q4ex311.htm Edgar Link pending
a2021-q4ex312.htm Edgar Link pending
a2021-q4ex321.htm Edgar Link pending
a2021-q4ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snbr-20220101.htm Edgar Link pending
snbr-20220101.xsd Edgar Link pending
snbr-20220101_cal.xml Edgar Link unprocessable
snbr-20220101_def.xml Edgar Link unprocessable
snbr-20220101_g1.jpg Edgar Link pending
snbr-20220101_htm.xml Edgar Link completed
snbr-20220101_lab.xml Edgar Link unprocessable
snbr-20220101_pre.xml Edgar Link unprocessable
table.jpg Edgar Link pending
table2.jpg Edgar Link pending